( NYSE:BMR,NASDAQ-NMS:OMER )

News from omeros corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 09, 2015, 16:10 ET Omeros Corporation Reports Third Quarter 2015 Financial Results

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and...


Nov 02, 2015, 07:00 ET Omeros Corporation to Announce Third Quarter 2015 Financial Results on November 9, 2015

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...


Oct 15, 2015, 07:00 ET Omeros Announces OMIDRIAssure™ to Expand Patient Access to Omidria®

 Omeros Corporation (NASDAQ: OMER) today announced that it has launched OMIDRIAssure™, a comprehensive reimbursement services program to...


Sep 03, 2015, 09:15 ET Omeros Files Infringement Suits Against Par

 Omeros Corporation (NASDAQ: OMER) today announced that it has filed patent infringement lawsuits against Par Pharmaceutical, Inc. and its...


Aug 18, 2015, 07:00 ET Omeros Announces Additional Positive Data in OMS721 Phase 2 Clinical Trial

Omeros Corporation (NASDAQ: OMER) today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of...


Aug 17, 2015, 07:00 ET Omeros Announces Plan to File Infringement Suit Against ANDA Filer

 Omeros Corporation (NASDAQ: OMER) today, in response to investor questions, announced that it plans to file a patent infringement lawsuit...


Aug 10, 2015, 16:11 ET Omeros Corporation Reports Second Quarter 2015 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...


Aug 07, 2015, 07:00 ET Omeros to Present at the 2015 Wedbush PacGrow Healthcare Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...


Aug 03, 2015, 07:00 ET Omidria® Approved for Commercialization Throughout the European Union and Additional Countries

 Omeros Corporation (NASDAQ: OMER) today announced that the European Commission (EC) has granted marketing authorization for Omidria...


Jul 31, 2015, 16:50 ET Omeros Corporation to Announce Second Quarter 2015 Financial Results on August 10, 2015

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...


Jul 23, 2015, 07:00 ET FDA Grants "Fast Track" to Omeros' Complement Inhibitor OMS721 for aHUS

 Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to OMS721...


Jun 17, 2015, 07:00 ET Rajiv Shah, M.D., Appointed to Omeros' Board of Directors

 Omeros Corporation (NASDAQ: OMER) today announced that Rajiv Shah, M.D., recent Administrator of the United States Agency for International...


Jun 16, 2015, 07:00 ET Omeros Announces Exclusive License Agreement for Omeros' Arthroscopic Product OMS103

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...


May 22, 2015, 07:00 ET Omidria® Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...


May 11, 2015, 16:06 ET Omeros Corporation Reports First Quarter 2015 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...


May 05, 2015, 07:00 ET Omeros Corporation to Announce First Quarter 2015 Financial Results on May 11, 2015

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and...


Apr 14, 2015, 07:00 ET European Regulatory Authority Approves Clinical Investigator's Request for Compassionate Use with Omeros Corporation's OMS721

 Omeros Corporation (NASDAQ: OMER) today announced that the presiding European regulatory authority has approved the company's investigational...


Apr 09, 2015, 16:31 ET Omeros to Present at the 14th Annual Needham Healthcare Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...


Apr 02, 2015, 08:15 ET Omeros Corporation Announces the U.S. Commercial Launch of Omidria™

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...


Mar 16, 2015, 16:05 ET Omeros Corporation Reports Fourth Quarter and Year-End 2014 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...


Mar 09, 2015, 18:03 ET Omeros Corporation to Announce Fourth Quarter and Full-Year 2014 Financial Results on March 16, 2015

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...


Feb 19, 2015, 07:00 ET Omeros Corporation's Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use

Omeros Corporation (NASDAQ: OMER) today announced that it has completed dosing of the low-dose cohort of patients in its ongoing Phase 2 clinical...


Feb 03, 2015, 17:01 ET Omeros Closes $84 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ: OMER) today announced that it has closed the underwritten public offering that was priced and allocated to investors on...


Jan 29, 2015, 08:32 ET Omeros Prices $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ: OMER) today announced that it has priced an underwritten public offering of 2,995,506 shares of its common stock at a...


Jan 28, 2015, 16:01 ET Omeros Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

 Omeros Corporation (NASDAQ: OMER) today announced its intention to offer, subject to market and other conditions, shares of its common...